Strafford will be offering a webinar/teleconference entitled "Pharma and Chemical Patent Applications: Meeting Written Description Requirement -- Demonstrating Evidence of Possession of the Invention, Navigating the Guidelines, Maintaining Chain of Priority" on July 26, 2016 from 1:00 to 2:30 pm (EDT). Thomas L. Irving of Finnegan Henderson Farabow Garrett & Dunner will provide guidance to patent counsel to ensure chemical and pharmaceutical patent applications meet the written description requirement, outline lessons for counsel from Federal Circuit and PTAB decisions, and offer perspectives and strategies to avoid challenges. The webinar will review the following issues:
• Guidelines for pharmaceutical application's written description support, e.g., a novel drug substance, product, and method(s) of treatments and manufacture;
• Preparing non-pharmaceutical, chemical application's written description in support of a novel compound, composition, and methods of use and compound manufacture;
• How a lack of written description support can be used in an AIA inter partes review before PTAB; and
• How a lack of written description support can be used before PTAB to attack claims by breaking the chain of priority to pre-AIA date benefit in an AIA post-grant review.
The registration fee for the webinar is $297. Those registering by July 1, 2016 will receive a $50 discount. Those interested in registering for the webinar, can do so here.
Comments